Breaking News, Promotions & Moves

Selexis Bolsters Business Development Team

Supports expanding base of partners using the SUREtechnology to advance complex biologics and vaccines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Selexis SA has made some personnel updates to support its expanding base of partners who rely on its SUREtechnology platform to advance complex biologics and vaccines. Specifically, the company promoted Yemi Onakunle and Marco Bocci to senior vice presidents of licensing and business development and has broadened its team in the U.S., with Boston- and San Francisco-based business development professionals. Additionally, the company has increased its investment in the Beacon optofluidic and singl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters